2 h. ago CD47 Inhibitors Drug Market Clinical Trials Insight 2026 | 80+ CD47 Inhibitor Drugs Currently in Clinical Trials – ResearchAndMarkets.com

DUBLIN — The “CD47 Inhibitors Drug Market Opportunity, Clinical Application by Indications & Clinical Trials Insight 2026” report has been added to ResearchAndMarkets.com’s offering. The quest for new cancer treatments has highlighted the CD47 pathway, an immune checkpoint that enables cancer to escape attack by the immune system. CD47 can be called the “don’t eat […]

Other

4 d. ago Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials

Key CMC achievements advance EB-003 on the path to first-in-human trials CAMBRIDGE, Mass. — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced significant progress in the chemistry, manufacturing, and controls (CMC) development of its lead candidate, EB-003. Important steps […]

Economics

2 w. ago Elon Musk’s Neuralink brain chip clinical trial in Canada raises ethical questions

Some doctors and bioethicists are raising concerns about a Toronto hospital’s partnership with a company founded by U.S. billionaire Elon Musk. University Health Network announced earlier this month that two quadriplegic Canadian patients had received Musk’s Neuralink brain implants as part of a study testing the safety and effectiveness of the wireless device. While critics […]

Other

2 w. ago Health Canada approves Celltrion’s Stoboclo® and Osenvelt®(CT

Stoboclo® and Osenvelt® (CT-P41) received Health Canada Notice of Compliance for all indications referencing Prolia® and Xgeva®, respectively1,2 The approval is based on the totality of evidence including results from a Phase III clinical trial in postmenopausal women with osteoporosis (PMO)3 Celltrion’s biosimilar portfolio continues to grow, expanding treatment options to reach more patients in […]

Science

2 w. ago ProteinQure Announces First Patient Dosed in Phase I Clinical Trial of PQ203 in Advanced Metastatic Cancer

TORONTO — ProteinQure, a Toronto-based biotech company pioneering computational peptide drug discovery, today announced the successful dosing of the first patient in its Phase I clinical trial evaluating PQ203 – a novel, rationally designed peptide therapeutic for advanced metastatic solid tumors. “Dosing our first patient with PQ203 represents a defining moment not just for ProteinQure, […]

Science

3 w. ago Ferring Japan announces PMDA Acceptance of NDA Filing for nadofaragene firadenovec

Nadofaragene firadenovec is the first and only non-replicating gene therapy administered intravesically, and it is already approved and launched in the US This represents the first filing of a novel non-chemotherapy approach in non-muscle invasive bladder cancer (NMIBC) treatment In the Japanese Phase 3 clinical trial, 75% complete response rate was achieved with single quarterly […]

Other

3 w. ago KFSHRC Conducts 48% of Clinical Trials in Saudi Arabia During the First Half of 2025

RIYADH, Saudi Arabia, Sept. 10, 2025 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital & Research Centre (KFSHRC) led Saudi healthcare institutions in clinical trials, conducting 48% of all clinical trials registered nationwide during the first half of 2025, with 104 active clinical trials and 80 new studies underway, providing patients with broader access to innovative […]

Other